Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Diagnosis: Breast Cancer

A PERCIST 1.0 based Computer Assisted Detection (CAD) system: Performance compared to an expert reader in the evaluation of breast cancer

Jeffrey Leal, Joyce Mhlanga, Muhammad Chaudhry and Richard Wahl
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 363;
Jeffrey Leal
1Radiology/Nuclear Medicine, Johns Hopkins University, Baltimore, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joyce Mhlanga
1Radiology/Nuclear Medicine, Johns Hopkins University, Baltimore, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Muhammad Chaudhry
1Radiology/Nuclear Medicine, Johns Hopkins University, Baltimore, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Wahl
1Radiology/Nuclear Medicine, Johns Hopkins University, Baltimore, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

363

Objectives To evaluate the performance of a Computer Assisted Detection (CAD) system based on the PERCIST 1.0 criteria as compared to an expert reader in tumor response assessment in breast cancer.

Methods Baseline FDG PET studies acquired on 18 patients in an IRB approved multi-site clinical trial for treatment of breast cancer were used in this analysis. Each study was evaluated independently by both an expert reader and by a PERCIST 1.0 based CAD program (developed in-house). For each study, the expert reader and CAD system independently applied the PERCIST 1.0 criteria by first measuring a 3cm VOI in the liver and calculating the PERCIST 1.0 threshold for disease detectability. Subsequently, tumor targets were identified. Multiple parameters, including PEAK-SUL and SUL-Max, were recorded for all tumor targets. The results of the CAD driven analysis were then compared against those of the expert reader.

Results The PERCIST 1.0 threshold measurements were not statistically different between the expert reader and the auto-detect algorithm used by the CAD system (t-test p-value = 0.98, ICC = 0.91). When PEAK-SUL was used to identify tumor targets, 15 (83%) studies were determined to be eligible for PERCIST 1.0 assessment, with the expert reader and CAD system performing identically (100% concordance). When using SUL-Max to identify tumor targets, the expert reader again found the same 15 (83%) studies as eligible for assessment whereas the CAD system identified 16 (89%) of the original 18 cases to be eligible (the same 15 as the expert reader, plus an additional case), an improvement over the expert reader by 7%.

Conclusions This work demonstrates that PERCIST 1.0 can be implemented in a CAD tool. It also demonstrates that this tool performs as well as an independent expert reader working alone when evaluating FDG-PET studies in cases of breast cancer. Use of such a tool may increase the efficiency of readers, as well as the objectivity and comparability of results amongst multiple readers

Back to top

In this issue

Journal of Nuclear Medicine
Vol. 52, Issue supplement 1
May 2011
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A PERCIST 1.0 based Computer Assisted Detection (CAD) system: Performance compared to an expert reader in the evaluation of breast cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
A PERCIST 1.0 based Computer Assisted Detection (CAD) system: Performance compared to an expert reader in the evaluation of breast cancer
Jeffrey Leal, Joyce Mhlanga, Muhammad Chaudhry, Richard Wahl
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 363;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
A PERCIST 1.0 based Computer Assisted Detection (CAD) system: Performance compared to an expert reader in the evaluation of breast cancer
Jeffrey Leal, Joyce Mhlanga, Muhammad Chaudhry, Richard Wahl
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 363;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Clinical Diagnosis: Breast Cancer

  • The role of scintimammography (SM) acquired with a breast specific gamma camera (BSGC) in breast cancer (BC) preoperative local staging
  • Investigation of 18F-FDG PET in the selection of patients with breast cancer candidate to sentinel node biopsy after neoadjuvant therapy - Update of an ongoing study
  • Volume-based parameters of primary tumor in F-18 FDG PET/CT in invasive ductal breast cancer for the prediction of lymph node metastasis
Show more Oncology: Clinical Diagnosis: Breast Cancer

Breast Cancer II: Diagnosis and Response

  • Does the PERCIST 1.0 minimum glycolytic activity metric allow evaluation of primary breast cancers?
  • Triple-negative breast cancer: Early assessment with 18F-FDG PET/CT during neoadjuvant chemotherapy identifies patients who are unlikely to achieve a pathological complete response
Show more Breast Cancer II: Diagnosis and Response

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire